康华药业 (870523.OC)

+ 收藏

现金流量表(康华药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 51,569,223.0888,936,574.8148,756,761.5867,031,447.8230,887,391.32
 收到其他与经营活动有关的现金(元) 262,757.404,649,030.70383,241.21520,969.59115,965.38
 经营活动现金流入小计(元) 51,831,980.4893,585,605.5149,140,002.7967,552,417.4131,003,356.70
 购买商品、接受劳务支付的现金(元) 23,204,589.0793,450,255.2344,292,288.2442,959,886.0414,330,222.09
 支付给职工以及为职工支付的现金(元) 5,181,856.308,170,390.444,076,699.797,041,763.533,238,711.16
 支付的各项税费(元) 787,034.35860,469.80612,948.69729,231.86594,416.02
 支付其他与经营活动有关的现金(元) 2,329,475.458,534,605.822,426,575.454,723,516.812,963,751.20
 经营活动现金流出小计(元) 31,502,955.17111,015,721.2951,408,512.1755,454,398.2421,127,100.47
 经营活动产生的现金流量净额(元) 20,329,025.31-17,430,115.78-2,268,509.3812,098,019.179,876,256.23
二、投资活动产生的现金流量
 收回投资收到的现金(元) 11,832,082.9087,456,180.99--73,548,466.24
 取得投资收益收到的现金(元) 32,723.82--1,112,302.74-5,634,595.732,205,781.41
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 116,739.21----
 收到其他与投资活动有关的现金(元) 1,815.22-73,561,117.22208,379,459.32-
 投资活动现金流入小计(元) 11,983,361.1587,456,180.9972,448,814.48202,744,863.5975,754,247.65
 购建固定资产、无形资产和其他长期资产支付的现金(元) 728,285.80599,251.494,997.60131,581.0974,240.00
 投资支付的现金(元) 24,262,206.3982,436,561.55--75,887,389.00
 支付其他与投资活动有关的现金(元) --72,635,757.80204,414,169.52-
 投资活动现金流出小计(元) 24,990,492.1983,035,813.0472,640,755.40204,545,750.6175,961,629.00
 投资活动产生的现金流量净额(元) -13,007,131.044,420,367.95-191,940.92-1,800,887.02-207,381.35
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 10,000,000.00----
 取得借款收到的现金(元) -10,000,000.00-20,000,000.0010,000,000.00
 筹资活动现金流入小计(元) 10,000,000.0010,000,000.00-20,000,000.0010,000,000.00
 偿还债务支付的现金(元) 10,000,000.0010,000,000.00-20,000,000.0010,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 122,444.97366,694.45178,722.225,333,958.315,166,347.21
 筹资活动现金流出小计(元) 10,122,444.9710,366,694.45178,722.2225,333,958.3115,166,347.21
 筹资活动产生的现金流量净额(元) -122,444.97-366,694.45-178,722.22-5,333,958.31-5,166,347.21
四、汇率变动对现金及现金等价物的影响(元) -9,955.06-3,649.47-4,224.49-79,399.82173.72
五、现金及现金等价物净增加额(元) 7,189,494.24-13,380,091.75-2,643,397.014,883,774.024,502,701.39
 加:期初现金及现金等价物余额(元) 7,275,782.1120,655,873.8620,655,873.8615,772,099.8415,772,099.84
 期末现金及现金等价物余额(元) 14,465,276.357,275,782.1118,012,476.8520,655,873.8620,274,801.23
补充资料:
 净利润(元) 1,811,229.214,552,228.771,633,828.23-4,745,205.90-2,047,568.54
 固定资产和投资性房地产折旧(元) 902,425.791,794,228.53922,877.541,901,638.09948,006.00
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 902,425.791,794,228.53922,877.541,901,638.09948,006.00
 无形资产摊销(元) 44,169.1288,338.2444,169.1288,338.2444,169.12
 长期待摊费用摊销(元) 91,354.5070,132.4635,645.5898,852.0846,540.09
 处置固定资产、无形资产和其他长期资产的损失(元) -14,925.20-19,316.19-
 公允价值变动损失(元) 102,093.47-464,537.281,211,374.32278,458.63137,682.29
 财务费用(元) 122,612.35367,569.45178,722.22362,361.09195,722.21
 投资损失(元) 6,098.052,596,073.741,035,626.185,853,918.683,493,375.84
 存货的减少(元) 11,136,386.59-17,752,944.74-6,542,711.43-1,679,384.693,049,262.50
 经营性应收项目的减少(元) 6,521,346.17-7,455,963.14-3,793,698.1310,074,579.585,246,293.16
 经营性应付项目的增加(元) -308,661.64-1,506,307.622,824,559.80550,842.81-779,820.48
 其他(元) --147,721.68---
 现金的期末余额(元) 14,465,276.357,275,782.1118,012,476.8520,655,873.8620,274,801.23
 减:现金的期初余额(元) 7,275,782.1120,655,873.8620,655,873.8615,772,099.8415,772,099.84
 现金及现金等价物的净增加额(元) 7,189,494.24-13,380,091.75-2,643,397.014,883,774.024,502,701.39
公告日期 2024-08-232024-04-262023-08-172023-04-272022-08-23
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院